Australian imaging technology developer Imagion Biosystems said it is moving its U.S. business operations to San Diego.
Imagion is developing MagSense, a bioimaging and nanomagnetic platform aimed at providing early detection of cancer. The firm expects to be fully operational in San Diego in the second quarter.